Company intelligence / Profile preview

Fesarius Therapeutics

Brooklyn, New York, United Statesfesariustherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Fesarius Therapeutics has received FDA marketing authorization for its flagship product, DermiSphere h DRT—a collagen-based hydrogel dermal regeneration template. The product supports stable vascularized tissue regeneration and has entered commercial use in the United States following a successful technology transfer to manufacturing partner Regenity Biosciences. Clinical results highlight improved patient outcomes in full-thickness skin loss management.

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: Hydrogel-based drug delivery therapyBiomaterial (collagen-based scaffold)Device (dermal regeneration template)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

DermiSphere hDRT

Pre-clinical

Indications: Full-thickness skin loss, Dermal regeneration, Wound healing

Partnerships

Regenity Biosciences (exclusive development/manufacturing/supply agreement for commercial production of DermiSphere h DRT)

Beyond the preview

Go deeper on Fesarius Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fesarius Therapeutics.

Explore the full profile